Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Aug;41(2):380-7.

Enhancement of IgE-mediated histamine release from human basophils by immune-specific lymphokines

Enhancement of IgE-mediated histamine release from human basophils by immune-specific lymphokines

S Ida et al. Clin Exp Immunol. 1980 Aug.

Abstract

Human leucocytes (basophils) release histamine when exposed to ragweed antigen E or anti-IgE. The present study shows that when leucocytes from BCG-positive donors are first incubated with PPD and then challenged with anti-IgE, histamine release is enhanced. In contrast, when leucocytes from BCG-negative donors are incubated with PPD and then challenged with anti-IgE there is no enhancement of histamine release. The enhancement of histamine release was detected within 24 hr after addition of PPD, but was maximal at 48 to 72 hr. Supernatant fluids collected from these leucocyte cultures revealed the presence of a soluble mediator(s) which, when incubated with leucocytes from BCG-negative donors, enhanced the release of histamine. Examination of the supernatant fluids from BCG-positive leucocyte cultures stimulated with PPD showed a correlation between histamine-release enhancing activity and interferon. Treatment of the culture fluids at pH 2.0 abolished the anti-viral activity, indicating that the interferon was of the type II or 'immune' class. The same treatment only partly abolished the histamine-release enhancing activity. It is concluded that immune-specific stimulation of leucocytes results in the release of soluble mediators that are capable of enhancing IgE-mediated histamine release.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Pediatr (Phila). 1966 Oct;5(10):586-92 - PubMed
    1. Science. 1969 Jun 20;164(3886):1415-7 - PubMed
    1. Br Med J. 1972 Aug 5;3(5822):323-7 - PubMed
    1. Ann Allergy. 1970 Feb;28(2):43-9 - PubMed
    1. J Pediatr. 1973 Apr;82(4):578-90 - PubMed

LinkOut - more resources